SCHEMBL29066231

SCHEMBL29066231

Cc1cc(-n2nc(C(=O)O)c(=O)[nH]c2=O)cc(C)c1Oc1c[nH]c(=O)c(C(C)C)c1

nearest known ligand 0.56

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ THRA P10827 14/20 0.56
▸ THRB P10828 17/20 0.50
▸ CYP2C9 P11712 2/20 0.39
▸ UGT1A1 P22309 1/20 0.39
▸ ABCG2 Q9UNQ0 1/20 0.39
▸ SLCO1B1 Q9Y6L6 1/20 0.39
▸ L3MBTL1 Q9Y468 2/20 0.39
▸ CYP2C8 P10632 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28655456 0.89 THRA (0.70) THRATHRBCYP2C9UGT1A1ABCG2
SCHEMBL24407902 0.85 THRB (0.54) THRATHRBCYP2C9UGT1A1ABCG2
SCHEMBL29066211 0.84 THRB (0.48) THRATHRBCYP2C9UGT1A1ABCG2
SCHEMBL24449337 0.82 THRB (0.56) THRATHRBCYP2C9UGT1A1ABCG2
SCHEMBL29066234 0.80 THRA (0.49) THRATHRBCYP2C9UGT1A1ABCG2
SCHEMBL29632829 0.80 THRB (0.61) THRATHRBCYP2C9UGT1A1ABCG2
SCHEMBL29527103 0.78 THRB (0.45) THRATHRBCYP2C9UGT1A1ABCG2
SCHEMBL22632496 0.77 THRA (0.91) THRATHRBCYP2C9UGT1A1ABCG2
SCHEMBL6219063 0.75 THRB (0.48) THRATHRBL3MBTL1
SCHEMBL29066203 0.75 THRA (0.67) THRATHRBCYP2C9UGT1A1ABCG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4240730-A1 2-PYRIDONES AS THYROID HORMONE RECEPTOR MODULATORS Aligos Therapeutics, Inc. (US) 2023-09-13 — — EP disclosed
CN-116710443-A 2-pyridones as thyroid hormone receptor modulators 阿利戈斯治疗公司 2023-09-05 — — CN disclosed
WO-2022099044-A1 2-PYRIDONES AS THYROID HORMONE RECEPTOR MODULATORS ALIGOS THERAPEUTICS, INC. (US) 2022-05-12 — — WO disclosed
Send feedback